Relationship between the status of BRAF V600 and EGFR gene mutation and clinicopathological features in patients with non-small cell lung cancer
10.13315/j.cnki.cjcep.2017.04.005
- VernacularTitle:非小细胞肺癌中BRAF V600、EGFR基因突变与临床病理特征的关系
- Author:
Yiming HAN
;
Lan RAO
;
Li DING
;
Jie ZHENG
;
Wan YANG
;
Jinhua SHEN
;
Xianjin ZOU
- Keywords:
lung neoplasms;
BRAF V600;
EGFR;
mutation
- From:
Chinese Journal of Clinical and Experimental Pathology
2017;33(4):375-378
- CountryChina
- Language:Chinese
-
Abstract:
Purpose To study the status of BRAF V600 and EGFR mutations in patients with non-small cell lung cancer (NSCLC) and to examine the relations between them.Methods BRAF V600 and EGFR mutations were detected with DNA sequencing.The relationship between BRAF V600,EGFR mutations and the clinicopathological features were analyzed.Results BRAF V600 mutations were detected in 11 (7.5％) of the 146 specimens.BRAF V600 mutations were found morelfrequently in non-smokers (P =0.045).There were no significant differences in age,gender,histological subtype and differentiation between patients with and without BRAF V600 mutations (P ＞ 0.05).EGFR mutations were detected in 68 (46.6％) of the 146 specimens.EGFR mutations were found more frequently in women,non-smokers and adenocarcinoma (P ＜ 0.05).Four tumors with BRAF V600 mutations (three V600 and one V600D) showed concomitant EGFR mutations (two DEL and two L858R).Conclusion BRAF V600 mutations in patients with NSCLC are found more frequently in non-smokers.There are no significant differences in age,gender,histological subtype and differentiation between patients with and without BRAF mutations.
